Fish oil boosts immunotherapy in esophageal cancer trial
NCT ID NCT07272382
First seen Jan 10, 2026 · Last updated May 24, 2026 · Updated 23 times
Summary
This study tests whether adding omega-3 fatty acids (EPA and DHA) to standard immunotherapy (PD-1 inhibitors) can improve muscle mass and overall outcomes in adults with advanced esophageal cancer. About 142 participants will receive either omega-3 or a placebo for 6 months alongside their cancer treatment. The goal is to see if this simple supplement can help patients maintain strength and respond better to therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.